ptcbio.com
域名年龄: 25年4个月12天HTTP/1.1 200 OK 服务器:Apache 动作:Accept-Encoding 缓存控制:no-store, 不缓存,必须更新, post-check=0, pre-check=0 类型:text/html; charset=UTF-8 Content-Encoding: gzip 访问时间:2015年01月20日 21:51:43 Keep-Alive: timeout=15, max=299 过期时间:1981年11月19日 16:52:00 其他指令:不缓存 连接:Keep-Alive 设置Cookie:X-Mapping-fjhppofk=6865B4AE8FA71398E2BE22BEB61D3B8C; path=/ 设置Cookie:sess=ehk5vkr65h5mvpiurgb7304ut3; path=/; domain=.ptcbio.com; HttpOnly 文件大小:9079 网站编码:UTF-8
About PTCOur ScienceNonsense ReadthroughAlternative Splicing ProgramTranscript RegulatorsOur HistoryLeadershipManagement TeamBoard of DirectorsScientific Advisory BoardCollaborationsContact UsLocationsTherapeutic FocusGenetic DisordersInfectious DiseasesOncologyAdditional ResourcesPipelineAtaluren (Translarna™)Ataluren PublicationsAtaluren FAQBMI1 - PTC596SMA Program – RG7800Clinical Trials: atalurenACT CF Clinical Trial OverviewACT CF Clinical Trial FAQACT CF Clinical Trial SitesDMD Clinical Trial OverviewInvestorsPress ReleasesEvents & PresentationsCorporate GovernanceManagement TeamBoard of DirectorsCommittee CompositionContact the BoardFinancial InformationSEC FilingsAnnual Report and ProxyStock InformationHistoric Stock LookupInvestment CalculatorAnalyst CoverageOwnership ProfileInvestor FAQsContact UsCareersOur Culture & ValuesCurrent OpeningsBenefits Contact Us About PTCOur ScienceNonsense ReadthroughAlternative Splicing ProgramTranscript RegulatorsOur HistoryLeadershipManagement TeamBoard of DirectorsScientific Advisory BoardCollaborationsContact UsLocationsTherapeutic FocusGenetic DisordersInfectious DiseasesOncologyAdditional ResourcesPipelineAtaluren (Translarna™)Ataluren PublicationsAtaluren FAQBMI1 - PTC596SMA Program – RG7800Clinical Trials: atalurenACT CF Clinical Trial OverviewACT CF Clinical Trial FAQACT CF Clinical Trial SitesDMD Clinical Trial OverviewInvestorsPress ReleasesEvents & PresentationsCorporate GovernanceManagement TeamBoard of DirectorsCommittee CompositionContact the BoardFinancial InformationSEC FilingsAnnual Report and ProxyStock InformationHistoric Stock LookupInvestment CalculatorAnalyst CoverageOwnership ProfileInvestor FAQsContact UsCareersOur Culture & ValuesCurrent OpeningsBenefits Contact Us PTC is committed to bringing hope to patients with rare and genetic diseases. Our scientists are finding new ways to regulate biology to control disease. We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases. Translating Science. Transforming Lives. View Our Pipeline About PTC Clinical Trials Careers at PTC Jan 07 PTC Therapeutics To Present At The 33rd Annual J.p. Morgan Healthcare Conference Jan 02 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Dec 23 PTC Therapeutics Begins Rolling Nda Submission To The Fda For Translarna To Treat Duchenne Muscular Dystrophy View all latest news SitemapContactLocationcareers © 2015 PTC Therapeutics. All rights reserved. | Terms of Use You are now leaving this website. If you would like to continue, click Continue.CancelContinue
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2025-12-22 15:47, Process in 0.0091 second.